// App-Quantinova.ai

3024.0 : Assessing readmission after axicabtagene ciloleucel immunotherapy.

Researchers

Presenter

  • Paula Perkins

Principal Investigators

  • Aisling Cearley

  • Angela Kirk

  • Erin Mullane

  • Mazyar Shadman

  • David G. Maloney

Medical Centers

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • Seattle Cancer Care Alliance, Seattle, WA

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • Univ of Washington, Bellevue, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • Cytokine

  • Twist-related protein 1

Drug/Treatment

  • Axicabtagene ciloleucel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved